Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

HealthLynked (HLYK) Amortization - Deferred Charges (2017 - 2025)

HealthLynked (HLYK) has disclosed Amortization - Deferred Charges for 7 consecutive years, with $109470.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortization - Deferred Charges fell 66.02% to $109470.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.2 million, a 37.36% increase, with the full-year FY2024 number at $1.3 million, up 207.65% from a year prior.
  • Amortization - Deferred Charges was $109470.0 for Q3 2025 at HealthLynked, down from $214580.0 in the prior quarter.
  • In the past five years, Amortization - Deferred Charges ranged from a high of $514403.0 in Q4 2024 to a low of $21020.0 in Q3 2022.
  • A 4-year average of $207846.3 and a median of $130422.0 in 2023 define the central range for Amortization - Deferred Charges.
  • Peak YoY movement for Amortization - Deferred Charges: surged 528.71% in 2023, then plummeted 66.02% in 2025.
  • HealthLynked's Amortization - Deferred Charges stood at $21020.0 in 2022, then skyrocketed by 392.88% to $103604.0 in 2023, then skyrocketed by 396.51% to $514403.0 in 2024, then plummeted by 78.72% to $109470.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Amortization - Deferred Charges are $109470.0 (Q3 2025), $214580.0 (Q2 2025), and $405113.0 (Q1 2025).